Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
69 hedge funds and large institutions have $41.6M invested in Ampio Pharmaceuticals Inc. in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 19 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $47M → $41.6M (-$5.42M)
14% less funds holding
Funds holding: 80 → 69 (-11)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
32% less call options, than puts
Call options by funds: $789K | Put options by funds: $1.17M
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$570K |
| 2 |
D.E. Shaw & Co
New York
|
+$212K |
| 3 |
Goldman Sachs
New York
|
+$192K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$144K |
| 5 |
State Street
Boston,
Massachusetts
|
+$143K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
Talkot Capital
Sausalito,
California
|
-$780K |
| 2 |
GIM
Guild Investment Management
Los Angeles,
California
|
-$727K |
| 3 |
IMS
Index Management Solutions
Philadelphia,
Pennsylvania
|
-$584K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$530K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$445K |
AMPE Hedge Fund Activity: Q4 2014 in Review
69 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2014, worth a combined $41.6M — down 12% from $47M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of AMPE and 9 opened new positions — a net loss of 10 holders — while 22 trimmed existing stakes and 18 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $570K. The largest seller was Talkot Capital, cutting an estimated $780K.
- 69 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2014, down from 80 in Q3 2014.
- Funds reported $41.6M of Ampio Pharmaceuticals Inc. stock for Q4 2014, down 12% quarter-over-quarter.
- 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2014 and 19 closed out, a net change of -10 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $570K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2014 was Talkot Capital, an estimated $780K sold.
Based on aggregated 13F filings for Q4 2014.